Biocompatibility Testing: The Invisible Safety Layer Behind Every Stent Before a coronary stent ever reaches a cath lab, it has to pass one of the most rigorous testing regimes in medical device development: biocompatibi…
InSitu was proud to take part in a recent stakeholders meeting at the Drug Regulatory Authority of Pakistan (DRAP), where industry leaders and regulators came together to discuss the future of healthcare supply in the co…
InSitu Technologies (Pvt.) Limited has been granted a license by the Drug Regulatory Authority of Pakistan (DRAP) to import registered medical devices, issued under the Medical Devices Rules, 2017. The license authorizes…
InSitu Technologies (Pvt) Limited has been granted a drug sale license by the licensing authority in Pakistan, permitting the company to sell, stock, and distribute registered pharmaceutical products under the Drug Act,…
InSitu Technologies leadership attended the Pakistan Hypertension League Conference, joining cardiologists and healthcare professionals from across the country for discussions on cardiovascular health and patient care. T…
InSitu Technologies leadership met with Dr. Bashir Hanif, Head of Department at Tabba Heart Institute , to discuss cardiovascular stent design and explore potential collaboration as InSitu works toward establishing local…
InSitu Technologies has manufactured cardiovascular and peripheral stents in the USA since 1995, supplying hospitals in over 40 countries. As we work toward establishing local manufacturing capability in Pakistan, this i…
Mr. Gohar Alam, CEO of InSitu Pakistan, and Col. Malik Asif met with Prof. Tahir Saghir, Executive Director of National Institute of Cardiovascular Diseases (NICVD), for a productive discussion. The conversation touched…
Mr. Gohar Alam, Col. Asif Malik and Mr. Nasir Hussain represented InSitu Pakistan at HealthAsia 2026, connecting with industry leaders, clinicians, and fellow exhibitors from across the healthcare and pharmaceutical sect…
We're proud to share that our InSitu Pakistan facility has successfully passed its district health inspection. This achievement reflects the hard work of our entire team in maintaining clean, safe, and compliant operatio…
Members of InSitu's leadership recently planted trees outside the InSitu Pakistan office, marking an early milestone for the new division. The gesture reflects the company's commitment to responsible, long-term growth, b…
InSitu Technologies (Pvt) Limited has formally submitted its application for a Form 8C New Distributor Drug Sale License (DSL) to the Directorate of Drugs Control, Punjab, marking a key regulatory milestone in the compan…
InSitu Technologies (Pvt.) Limited is pleased to announce that its application for a new import establishment license was received by the Drug Regulatory Authority of Pakistan (DRAP) on July 27, 2026. The application was…